{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:04:00Z","timestamp":1789693440068,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019331","name":"Henan Medical Science and Technique Foundation","doi-asserted-by":"publisher","award":["SBGJ202303004"],"award-info":[{"award-number":["SBGJ202303004"]}],"id":[{"id":"10.13039\/501100019331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["224000510005"],"award-info":[{"award-number":["224000510005"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303099"],"award-info":[{"award-number":["82303099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112819","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:23:33Z","timestamp":1786548213000},"page":"112819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nilotinib inhibition of clear cell renal cell carcinoma proliferation and synergistic enhancement of sunitinib efficacy"],"prefix":"10.1016","volume":"148","author":[{"given":"Yifeng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cellsig.2026.112819_bb0005","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/2159-8290.CD-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112819_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2026.112819_bb0015","article-title":"Novel molecular subtypes and related score based on histone acetylation modification in renal clear cell carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112819_bb0020","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112819_bb0025","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-22-3105","article-title":"ZDHHC2-mediated AGK palmitoylation activates AKT-mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112819_bb0030","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41401-022-00862-1","article-title":"PTEN loss confers sensitivity to rapalogs in clear cell renal cell carcinoma","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112819_bb0035","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112819_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.trecan.2020.02.017","article-title":"Lipid in renal carcinoma: queen bee to target?","volume":"6","author":"Tan","year":"2020","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112819_bb0045","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","article-title":"Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation","volume":"24","author":"Ackerman","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02436-8","article-title":"High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth","volume":"20","author":"Wang","year":"2022","journal-title":"BMC Med."},{"issue":"7747","key":"10.1016\/j.cellsig.2026.112819_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16288-4","article-title":"Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor","volume":"11","author":"Guan","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0021-9150(00)00615-8","article-title":"Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia","volume":"157","author":"Insull","year":"2001","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112819_bb0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2026.112819_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105070","article-title":"VHL mutation drives human clear cell renal cell carcinoma progression through PI3K\/AKT-dependent cholesteryl ester accumulation","volume":"103","author":"Zhang","year":"2024","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112819_bb0080","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10637-020-00899-1","article-title":"A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma","volume":"38","author":"Smith","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112819_bb0090","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2017.10.037","article-title":"Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling","volume":"171","author":"Lee","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-021-09996-w","article-title":"Lipid metabolism reprogramming in renal cell carcinoma","volume":"41","author":"Heravi","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112819_bb0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112819_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112819_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1039\/D3FO03716A","article-title":"Fatty acid isomerism: analysis and selected biological functions","volume":"15","author":"Wang","year":"2024","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112819_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.crvi.2010.01.014","article-title":"Role of very-long-chain fatty acids in plant development, when chain length does matter","volume":"333","author":"Bach","year":"2010","journal-title":"C. R. Biol."},{"key":"10.1016\/j.cellsig.2026.112819_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116230","article-title":"Natural compounds efficacy in ophthalmic diseases: a new twist impacting ferroptosis","volume":"172","author":"Yuan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112819_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4062\/biomolther.2021.107","article-title":"Bioactive lipids and their derivatives in biomedical applications","volume":"29","author":"Park","year":"2021","journal-title":"Biomol. Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112819_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem."},{"issue":"679","key":"10.1016\/j.cellsig.2026.112819_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6288","article-title":"Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models","volume":"15","author":"Eyme","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12943-025-02457-w","article-title":"Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting","volume":"24","author":"Deng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"7808","key":"10.1016\/j.cellsig.2026.112819_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-020-2290-0","article-title":"Structural basis for catalysis and substrate specificity of human ACAT1","volume":"581","author":"Qian","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112819_bb0150","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1194\/jlr.M026799","article-title":"Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine","volume":"53","author":"Hutchins","year":"2012","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112819_bb0155","doi-asserted-by":"crossref","first-page":"Of11","DOI":"10.1158\/2159-8290.CD-NB2018-045","article-title":"FDA expands indication for nilotinib","volume":"8","year":"2018","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112819_bb0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/1078-0432.CCR-19-0090","article-title":"Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia","volume":"26","author":"Hijiya","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112819_bb0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.25947","article-title":"Cardiovascular safety of nilotinib in Alzheimer disease","volume":"89","author":"Tan","year":"2021","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112819_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/17512433.2021.1894129","article-title":"Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies","volume":"14","author":"Wang","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112819_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092478","article-title":"Pharmacokinetics of four tyrosine kinase inhibitors in adult and paediatric chronic myeloid leukaemia patients","volume":"11","author":"Allegra","year":"2023","journal-title":"Biomedicines"},{"issue":"30","key":"10.1016\/j.cellsig.2026.112819_bb0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024302118","article-title":"Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay","volume":"118","author":"Jang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112819_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/0008-5472.CAN-22-1533","article-title":"Plk1 inhibitors and abiraterone synergistically disrupt mitosis and kill cancer cells of disparate origin independently of androgen receptor signaling","volume":"83","author":"Patterson","year":"2023","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112819_bb0190","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.7150\/thno.99926","article-title":"Gut microbiota depletion and FXR inhibition exacerbates zonal hepatotoxicity of sunitinib","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112819_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112371","article-title":"Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts","volume":"9","author":"Miles","year":"2014","journal-title":"PLoS One"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:09:54Z","timestamp":1789690194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0898656826004778"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112819","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nilotinib inhibition of clear cell renal cell carcinoma proliferation and synergistic enhancement of sunitinib efficacy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112819"}}